Leaders in Pharmaceutical Business Intelligence (LPBI) Group

11/18/2015 3:15 p.m. Perspectives From Professional Societies and Personalized Medicine Around the World, 11th Annual Personalized Medicine Conference, November 18-19, 2015, Harvard Medical School

Reporter: Aviva Lev-Ari, PhD, RN

 

Live Press Coverage in REAL TIME

Aviva Lev-Ari, PhD, RN

Director & Founder, Leaders in Pharmaceutical Business Intelligence, Boston

Co-Founder, GDE

 

 

3:15 p.m. – Conversation

Perspectives From Professional Societies

Our Conference is organized in association with the Personalized Medicine Coalition, American Association for Cancer Research, American Medical Association and the American Society for Human Genetics. All of these and many other scientific and medical organizations have established programs to educate their membership about the principles of personalized medicine and how it is influencing scientific and medical discovery as well implementation to improve human health. Representatives from these different organizations will discuss ways to improve the literacy on personalized medicine.

• Procedures, methods, similar diseases
• Physician’s practices on Precision medicine
• Advocacy in Wash DC
• Innovations – in chronic disease to intervention

1. Some Cancers are chronic and need be treated in the Community
2. CDC other organization to Scale to State level
3. DM – 1 in 3 are preDiabetics
4. 130 start ups: Good Ideas in HealthCare
5. Innovation Center in South of Market in SF
6. Personalize Medicine: Story and the Facts, a genomics sequences in absence of the social context as part of the story
7. Cardiovascular: Blood Pressure measure
8. MDs Students are not trained to learn to listen, communications, big data, genomics
9. 2% R&D Budget — we need higher – robust innovation
10. Operations: Medical Operation revenues vs Cost
11. Payers are less interested in quality
12. Value to Patients

COMMENTS from Audience

• Pathologists need to be reimbursed to do the diagnosis on specimen and genomics
• Education and training of Young MD students
• Colon Cancer Centers of Centers of Excellence: Genetics data vs data surgeon needs for complete exceesion during tumor removal by the Surgeon
• Standardize the collection of tissue sample
• DECISION SUPPORT for Genomics research, public domain, continue updates
• Insurance need to pay for one test at a time
• conserve tissue for Genomics analysis
• Professional Guidelines like AHA are very important

 

4:15 p.m. – Panel Discussion

Personalized Medicine Around the World

Personalized Medicine cuts across all disciplines of biology and medicine and does not have any national boundaries. However the healthcare systems in each country around the world are different and each country is taking its own unique path toward providing personalized medicine to its people. We will hear different examples from the two largest countries, China and India as well as perspectives from international business organizations.

• chronic vascular disease: Ischemia, stroke, ER, Hyperpression, Migraine,
• Personalized Medicine will reach the goal in efficacy, over 10,000 patients served a year
• 45 Chapters since 1984, priority in China and US prevention
• NGS initiative in China in the last two years
• B-to-B vs C-to-Businessne

– See more at: http://personalizedmedicine.partners.org/Education/Personalized-Medicine-Conference/Program.aspx#sthash.O4Znb9kq.dpuf

To Follow LIVE CONFERENCE COVERAGE PLEASE FOLLOW ON TWITTER USING

Meeting #: #PMConf

Meeting @: @HarvardPMConf

@PartnersPersMed

 

Overall good meeting #s:

#personalizedmedicine

#powerofgenomics

#genomics

#pharmanews

 

AND FOLLOW these @

@pharma_BI

@AVIVA_1950

@BiotechNews

TALK SPECIFIC # and @

	3:15 PM	Perspectives From Professional Societies Opening Speaker & Moderator: Cynthia Morton, Ph.D. William Lambert Richardson Professor of OB/Gyn and Reproductive Biology and Professor of Pathology, Harvard Medical School; Director of Cytogenetics, Brigham and Women’s Hospital Panelists José Baselga, M.D., Ph.D. Physician in Chief and Chief Medical Officer, Memorial Sloan Kettering Cancer Center Richard Friedberg, M.D., Ph.D. Chair, Department of Pathology, Diagnostic Medicine Services Bay State Health James Madara, M.D. Executive Vice President and CEO, American Medical Association	#disease #populationgenetics #health #fibroids #womenshealth #geneticfactors #PopulationHealth	@PartnersNews @BWHResearch @Brigham @AmerMedicalAssn @HarvardHealth @harvardmed @sloan_kettering   @Baystate_Health
	4:15 pm	Panel Discussion Personalized Medicine Around the World Opening Speaker & Moderator: Gary Palmer, M.D., J.D., MBA, MPH Chief Medical Officer, NantHealth   Panelists: Vijay Chandru, Ph.D. Co-Founder, Chairman and CEO, Strand Life Sciences Xishan Hao, M.D., FACS Professor, Academician of Chinese Academy of Engineering; President, Chinese Anti-Cancer Association; Director, Tianjin Cancer Research Institute Jack Wang CEO, Biomobie Regenerative Medicine Co., Ltd.	#personalizedmedicine #personalmed #disease #populationgenetics #health #globalhealth #PopulationHealth #NGS #HealthAsia #China #cancer #biotech #Biomobie	@nanthealth @StrandLife @CDCGlobal